Particularly in NF1-associated MPNST, it is generally accepted that alterations in NF1, CDKN2A, TP53, and SUZ12 are involved in tumor progression from benign to malignant tumors. This evidence concerns the gene SUZ12 and malignant peripheral nerve sheath tumor.